Want to see PL:CTX full AI Analyst Report?
Captor Therapeutics SA (CTX) Ratios
1 Followers
Captor Therapeutics SA Ratios
PL:CTX's free cash flow for Q2 2026 was zł-12.16M. For the 2026 fiscal year, PL:CTX's free cash flow was decreased by zł-176.00K and operating cash flow was zł-11.98M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.27 | 3.90 | 3.32 | 7.57 | 7.98 |
| Quick Ratio | 2.27 | 3.90 | 3.32 | 7.57 | 7.98 |
| Cash Ratio | 0.72 | 1.96 | 2.83 | 5.30 | 7.21 |
| Solvency Ratio | -2.27 | -1.45 | -2.32 | -1.73 | -1.30 |
| Operating Cash Flow Ratio | -2.44 | -1.58 | -1.95 | -1.71 | -1.74 |
| Short-Term Operating Cash Flow Coverage | -17.62 | -11.52 | -20.63 | -6.17 | -5.43 |
| Net Current Asset Value | zł 17.28M | zł 55.06M | zł 60.57M | zł 84.65M | zł 111.22M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.06 | 0.04 | 0.06 | 0.06 |
| Debt-to-Equity Ratio | 0.15 | 0.09 | 0.05 | 0.07 | 0.07 |
| Debt-to-Capital Ratio | 0.13 | 0.08 | 0.05 | 0.07 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.70 | 1.36 | 1.41 | 1.17 | 1.16 |
| Debt Service Coverage Ratio | -20.84 | -10.34 | -22.71 | -6.57 | -4.33 |
| Interest Coverage Ratio | -188.01 | -102.43 | -226.06 | -66.26 | -79.27 |
| Debt to Market Cap | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest Debt Per Share | 0.70 | 1.30 | 0.88 | 1.81 | 2.08 |
| Net Debt to EBITDA | 0.15 | 1.02 | 1.11 | 2.27 | 4.50 |
| Profitability Margins | |||||
| Gross Profit Margin | -13.99% | 40.59% | 52.28% | 77.21% | 81.41% |
| EBIT Margin | -1141.78% | -240.06% | -532.22% | -385.62% | -796.91% |
| EBITDA Margin | -1048.05% | -208.09% | -490.60% | -308.16% | -612.39% |
| Operating Profit Margin | -1141.78% | -282.84% | -553.11% | -418.91% | -795.48% |
| Pretax Profit Margin | -901.22% | -242.82% | -534.25% | -391.94% | -817.16% |
| Net Profit Margin | -901.22% | -242.82% | -534.69% | -391.94% | -817.16% |
| Continuous Operations Profit Margin | -901.22% | -242.82% | -534.69% | -391.94% | -817.16% |
| Net Income Per EBT | 100.00% | 100.00% | 100.08% | 100.00% | 100.00% |
| EBT Per EBIT | 78.93% | 85.85% | 96.59% | 93.56% | 102.72% |
| Return on Assets (ROA) | -104.93% | -43.92% | -72.55% | -31.76% | -22.69% |
| Return on Equity (ROE) | -178.86% | -59.60% | -101.97% | -37.26% | -26.23% |
| Return on Capital Employed (ROCE) | -211.89% | -66.34% | -103.48% | -38.51% | -24.93% |
| Return on Invested Capital (ROIC) | -195.82% | -61.35% | -96.55% | -35.84% | -23.03% |
| Return on Tangible Assets | -108.12% | -44.13% | -72.78% | -31.99% | -22.75% |
| Earnings Yield | -10.57% | -19.50% | -15.19% | -5.38% | -4.39% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.84 | 0.41 | 1.05 | 0.95 | 0.34 |
| Payables Turnover | 2.09 | 3.55 | 0.97 | 0.49 | 0.32 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.95 | 1.79 | 1.63 | 0.86 | 0.32 |
| Asset Turnover | 0.12 | 0.18 | 0.14 | 0.08 | 0.03 |
| Working Capital Turnover Ratio | 0.12 | 0.26 | 0.18 | 0.09 | 0.07 |
| Cash Conversion Cycle | -79.71 | 779.48 | -29.24 | -365.96 | -59.03 |
| Days of Sales Outstanding | 95.17 | 882.32 | 347.53 | 385.73 | 1071.92 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 174.87 | 102.84 | 376.76 | 751.69 | 1130.96 |
| Operating Cycle | 95.17 | 882.32 | 347.53 | 385.73 | 1071.92 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -6.58 | -6.79 | -11.24 | -5.51 | -6.90 |
| Free Cash Flow Per Share | -6.62 | -6.88 | -11.88 | -5.72 | -8.14 |
| Dividend Paid and CapEx Coverage Ratio | -172.94 | -74.62 | -17.37 | -25.73 | -5.57 |
| Capital Expenditure Coverage Ratio | -172.94 | -74.62 | -17.37 | -25.73 | -5.57 |
| Operating Cash Flow Coverage Ratio | -10.16 | -5.61 | -13.82 | -3.30 | -3.48 |
| Operating Cash Flow to Sales Ratio | -7.79 | -2.00 | -3.95 | -2.51 | -7.14 |
| Free Cash Flow Yield | -9.19% | -16.27% | -11.88% | -3.57% | -4.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -9.46 | -5.13 | -6.58 | -18.58 | -22.79 |
| Price-to-Sales (P/S) Ratio | 85.26 | 12.45 | 35.19 | 72.82 | 186.20 |
| Price-to-Book (P/B) Ratio | 16.92 | 3.06 | 6.71 | 6.92 | 5.98 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.88 | -6.15 | -8.41 | -27.97 | -22.10 |
| Price-to-Operating Cash Flow Ratio | -10.94 | -6.23 | -8.90 | -29.06 | -26.07 |
| Price-to-Earnings Growth (PEG) Ratio | 1.22 | 0.11 | -0.09 | -2.04 | -0.22 |
| Enterprise Value Multiple | -7.99 | -4.96 | -6.06 | -21.36 | -25.91 |
| Enterprise Value | 390.15M | 163.48M | 392.65M | 602.82M | 632.45M |
| EV to EBITDA | -7.99 | -4.96 | -6.06 | -21.36 | -25.91 |
| EV to Sales | 83.72 | 10.33 | 29.74 | 65.82 | 158.67 |
| EV to Free Cash Flow | -10.68 | -5.10 | -7.11 | -25.29 | -18.83 |
| EV to Operating Cash Flow | -10.74 | -5.17 | -7.52 | -26.27 | -22.21 |
| Tangible Book Value Per Share | 4.04 | 13.75 | 14.83 | 22.92 | 30.00 |
| Shareholders’ Equity Per Share | 4.26 | 13.84 | 14.90 | 23.11 | 30.09 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.84 | 3.40 | 2.84 | 2.20 | 0.97 |
| Net Income Per Share | -7.61 | -8.25 | -15.19 | -8.61 | -7.89 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.79 | 1.01 | 1.00 | 1.02 | 1.03 |
| Research & Development to Revenue | 9.20 | 2.19 | 4.91 | 4.82 | 5.80 |
| SG&A to Revenue | 2.08 | 1.04 | 1.22 | 2.14 | 4.90 |
| Stock-Based Compensation to Revenue | 0.00 | 0.13 | 0.35 | 0.87 | 2.38 |
| Income Quality | 0.86 | 0.82 | 0.74 | 0.64 | 0.87 |
Currency in PLN
